| Issue Date | Title | Author(s) |
| 2016 | Assessing the Economic Burden and Health Care Utilization of Attention Deficit/Hyperactivity Disorder Among Us Medicaid Patients | Zhang Q; Zhao, Y; Keshishian, A; Xie, L; Yuce, H; Başer, Onur |
| 2017 | A Comparative Analysis of the Health Care Utilization and Costs of Patients Diagnosed With and Without Liver Cancer in the Us Medicare Population | Ogbomo, A.; Lin, Y.; Keshishian, A; Xie, L; Yuce, H; Başer, Onur |
| 2016 | Comparing Health Care Resource Utilization and Costs Among Obese Patients in the Us Medicaid Population | Zhang, Q; Zhao, Y; Keshishian, A; Xie, L; Yuce H.; Başer, Onur |
| 2015 | Comparison of Major-Bleeding Risk and Health Care Costs Among Treatment-Naïve Non-Valvular Atrial Fibrillation Patients Initiating Apixaban, Dabigatran, Rivaroxaban, or Warfarin | Amin, Alpesh; Keshishian, A; Xie, L; Başer, Onur ; Price, K; Vo, L; Singh, P; Bruno, A; Mardekian, J; Tan, W; Singhal, S; Patel, C; Odell, K; Trocio J. |
| 2015 | Comparison of Short Term Bleeding-Related Health Care Utilization and Costs Among Treatment-Naïve Non-Valvular Atrial Fibrillation Patients Initiating Apixaban, Dabigatran, Rivoxaban or Warfarin | Keshishian, A; Xie, L; Başer, Onur ; Price, K; Vo, L; Singh, P; Bruno, A; Mardekian, J; Tan, W; Singha, S; Patel C; Odell, K; Trocio J. |
| 2016 | Demographic and Socioeconomic Characteristics That Impact Selection of Oral Anticoagulants Among Non-Valvular Atrial Fibrillation Patients | Keshishian, A; Du, J; Xie, L; Yuce H.; Başer, Onur |
| 2015 | Early Comparison of Major Bleeding, Stroke and Associated Medical Costs Among Treatment-Naive Non-Valvular Atrial Fibrillation Patients Initiating Apixaban, Dabigatran, Rivaroxaban or Warfarin | Alpesh, A; Keshishian, A; Xie, L; Başer, Onur ; Price, K; Vo, L; Singh, P; Bruno, A; Mardekian, J; Tan, W; Singhal, S; Patel, C; Odell, K; Trocio J. |
| 2016 | The Economic Impact of Symptomatic Menopause Among Low-Socioeconomic Women in the United States | Başer, Onur ; Keshishian, A; Xie, Lin; Wang, Yuexi |
| 2016 | Evaluating Asthma-Related Expenses and Health Care Resource Utilization Among Children in the Us Medicaid Population | Zhang, Q; Zhao, Y; Keshishian, A; Xie L; Yuce H.; Başer, Onur |
| 2015 | Evaluating Fracture-Related Expenses and Health Care Resource Utilization Among Post-Menopausal Women in the Us Medicaid Population | Xie, L.; Keshishian, A; Wang, Y.; Başer, Onur |
| 2016 | Evaluating the Economic Burden and Health Care Utilization of Coronary Artery Disease in the Us Medi-Cal Population | Zhang, Q; Zhao, Y; Keshishian, A; Xie, L; Yuce, H; Başer, Onur |
| 2016 | Examination of the Economic Burden of Dyslipidemia in the Veterans Health Administration Population | Keshishian, A; Tan, H; Xie, L; Başer, Onur |
| 2015 | Examining the Economic Burden and Health Care Utilization of Menopausal Women in the U.s. Medicaid Population | Keshishian, A; Wang, Y; Xie, L; Başer, Onur ; Yuce H. |
| 2015 | Pcn62 - Assessing the Economic Burden and Health Care Resource Utilizations of Us Medica Re Patients With Myeloproliferative Neoplasms | Keshishian, A; Du, J; Xie, L; Başer, Onur |
| 2015 | Pcn62 - Assessing the Economic Burden of Us Medicare Patients Diagnosed With Non-hodgkin's Lymphoma | Xie, L; Keshishian, A; Du, J; Başer, Onur |
| 2015 | Pih13 - Examining the Fracture-Related Cost Burden and Health Care Resource Utilization Post-Menopause in the Us Medicare Population | Xie, L; Keshishian, A; Du, J; Başer, Onur |
| 2015 | Pmh21 - Comparing the Healthcare Utilization and Costs of Early- and Late-Stage Alzheimer's Disease Patients Residing in Long-Term Care Facilities | Xie, L.; Keshishian, A; Wang, Y.; Başer, Onur |
| 2016 | Real-World Comparison of Major Bleeding and Associated Costs Among Treatment-Naïve Nonvalvular Atrial Fibrillation Patients Initiating Apixaban or Warfarin | Amin, Alpesh; Keshishian, A; Xie L; Başer, Onur ; Price, K; Vo, L; Mardekian, J; Mendoza, M; Singhal, S; Patel, C; Odell, K; Trocio, J |
| 2016 | Real-World Comparison of Major Bleeding Risk Among Untreated Non-Valvular Atrial Fibrillation Patients and Those Initiating Apixaban, Dabigatran, Rivaroxaban, or Warfarin | Amin, Alpesh; Keshishian, A; Xie, L; Başer, Onur ; Price, K; Lien Vo; Mardekian, J; Mendoza, M; Singhal, S; Patel, C; Odell, K; Trocio J. |
| 2017 | Risk of Stroke/Systemic Embolism, Major Bleeding and Associated Costs in Non-Valvular Atrial Fibrillation Patients Who Initiated Apixaban, Dabigatran or Rivaroxaban Compared With Warfarin in the United States Medicare Population | Amin, Alpesh; Lien Vo; Trocio, Jeffrey; Keshishian, A; Liu, Xianchen; Mardekian, Jack; Zhang, Qisu; Rosenblatt, Lisa; Dina, Oluwaseyi; Başer, Onur ; Le, Hannah |
